| 11986509 |
Oligosaccharide formulations of kappa opioid receptor agonists |
Stephen O'Connor |
2024-05-21 |
| 11872265 |
Diketopiperazine salts for drug delivery and related methods |
Andrea Leone-Bay, Destardi Moye-Sherman |
2024-01-16 |
| 11684674 |
Oral formulations of kappa opioid receptor agonists |
Stephen O'Connor |
2023-06-27 |
| 11192862 |
Microcrystalline diketopiperazine compositions and methods |
Joseph J. Guarneri, Marshall L. Grant |
2021-12-07 |
| 11033629 |
Oral formulations of kappa opioid receptor agonists |
Stephen O'Connor |
2021-06-15 |
| 10912821 |
Diketopiperazine salts for drug delivery and related methods |
Andrea Leone-Bay, Destardi Moye-Sherman |
2021-02-09 |
| 10745359 |
Microcrystalline diketopiperazine compositions and methods |
Joseph J. Guarneri, Marshall L. Grant |
2020-08-18 |
| 10583176 |
Diketopiperazine salts for drug delivery and related methods |
Andrea Leone-Bay, Destardi Moye-Sherman |
2020-03-10 |
| 10421729 |
Microcrystalline diketopiperazine compositions and methods |
Joseph J. Guarneri, Marshall L. Grant |
2019-09-24 |
| 10376466 |
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
Marshall L. Grant |
2019-08-13 |
| 10130685 |
Diketopiperazine salts for drug delivery and related methods |
Andrea Leone-Bay, Destardi Moye-Sherman |
2018-11-20 |
| 10130581 |
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
Marshall L. Grant |
2018-11-20 |
| 9675674 |
Diketopiperazine salts for drug delivery and related methods |
Andrea Leone-Bay, Destardi Moye-Sherman |
2017-06-13 |
| 9399065 |
Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin |
Roderike Pohl, Robert R. Hauser, Errol De Souza, Ming Li |
2016-07-26 |
| 9381247 |
Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain |
Roderike Pohl, Robert R. Hauser, Ming Li |
2016-07-05 |
| 9259471 |
Diketopiperazine salts for drug delivery and related methods |
Andrea Leone-Bay, Destardi Moye-Sherman |
2016-02-16 |
| 9241903 |
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
Marshall L. Grant |
2016-01-26 |
| 8653085 |
Diketopiperazine salts for drug delivery and related methods |
Andrea Leone-Bay, Destardi Moye-Sherman |
2014-02-18 |
| 8512932 |
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
Marshall L. Grant |
2013-08-20 |
| 8278308 |
Diketopiperazine salts for drug delivery and related methods |
Andrea Leone-Bay, Destardi Moye-Sherman |
2012-10-02 |
| 8039431 |
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
Marshall L. Grant |
2011-10-18 |
| 7833549 |
Dry powder formulations of antihistamine for nasal administration |
Solomon S. Steiner |
2010-11-16 |
| 7833550 |
Dry powder formulations of antihistamine for nasal administration |
Solomon S. Steiner |
2010-11-16 |
| 7820676 |
Diketopiperazine salts for drug delivery and related methods |
Andrea Leone-Bay, Destardi Moye-Sherman |
2010-10-26 |
| 5712269 |
M.sub.2 receptor ligand for the treatment of neurological disorders |
R. Tyler McCabe, Christopher A. Rhodes |
1998-01-27 |